Amphastar Pharmaceuticals AMPH Interest Income
Interest Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's interest income?
- Amphastar Pharmaceuticals (AMPH) reported interest income of $2.4M in Q1 2026.
- How has Amphastar Pharmaceuticals's interest income changed year-over-year?
- Amphastar Pharmaceuticals's interest income increased by 14.9% year-over-year, from $2.09M to $2.4M.
- What is the long-term trend for Amphastar Pharmaceuticals's interest income?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's interest income has grown at a 94.9% compound annual growth rate (CAGR), from $601K to $8.68M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.